BioSpace News Archive

The most challenging vascular injuries involve trauma caused to the abdomen, pelvis, and retroperitoneal structures of the body.

The healthcare industry research report on global surgical stents market throughly examines the industry landscape with the help of information gathered through various industry leading sources.

Wilmington, Delaware, United States, Transparency Market Research Inc.: Rising cases of cardiac disorders, Parkinson’s disease, and epilepsy are prognosticated to boost the sales growth in the global microelectronic medical implants market during the forecast period of 2021 to 2031.

Hyloris Pharmaceuticals SA announced positive results from a Phase 1 study of HY-004, an antifibrinolytic agent, tranexamic acid, as an oral mouth rinse proprietary formulation in healthy patients following tooth extraction.

Fact.MR – a market research and competitive intelligence provider, projects the global medical camera market to have a positive outlook, expanding at a CAGR of above 8% across the 2021-2031 forecast period.

Poolbeg Pharma has received ethics and competent authority approval to commence its Lipopolysaccharide human challenge clinical trial for POLB 001, a strain agnostic, small molecule immunomodulator which aims to address the unmet medical need for a treatment for severe influenza.

Nicox SA, an international ophthalmology company, provided financial and business highlights for second quarter 2022 for Nicox SA and its subsidiaries and updated on key upcoming milestones.

Forbion, a leading European life sciences venture capital firm, today announces the appointments of Dr. Peter Høngaard Andersen and Dr. Matt Cooper as Operating Partner and Venture Partner, respectively, expanding the Forbion team, network and expertise investing in drug development companies that impact the future of medicine, especially in the disease areas of CNS, autoimmunity and inflammation.

Fact.MR, a market research and competitive intelligence provider: The global Influenza Diagnostics market reached a valuation of US$ 2.5 Bn in 2020, and is anticipated to top US$ 4 Bn by 2031, expanding at a CAGR of 5%.

The healthcare industry research report on global venipuncture needles and syringes market offers a holistic evaluation of the current landscape of the industry.